Rohto Pharmaceutical Co.,Ltd. (4527.T)

Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang

Japan's Mitsui & Co said on Thursday it had teamed up with Rohto Pharmaceutical Co to buy Eu Yan Sang International in a deal valuing the Singapore-based traditional Chinese medicines firm at S$800 million ($594 million). Mitsui said in a statement that a special purpose company jointly owned by Mitsui and Rohto would acquire around 86% of Eu Yan Sang from Righteous Crane Holding. Righteous Crane Holding is owned by a fund managed by Tower Capital Asia, a unit of Temasek Holdings and founding family members of Eu Yan Sang, according to a separate statement issued by Tower Capital Asia on Thursday.